pancreas adenocarcinoma
Showing 1 - 25 of 42
Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)
Not yet recruiting
- Pancreas Cancer
- Pancreas Adenocarcinoma
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023
Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)
Withdrawn
- Advanced Solid Tumor
- +9 more
- (no location specified)
Oct 16, 2023
Pancreas Cancer, Pancreas Adenocarcinoma, Lymph Node Metastasis Trial in Denmark, Sweden (PALN resection)
Recruiting
- Pancreas Cancer
- +2 more
- PALN resection
-
Odense, Denmark
- +5 more
Sep 26, 2023
Improving Pancreatic Cancer Care by Use of Computational Science
Recruiting
- Pancreatic Cancer
- +5 more
- No interventions
-
Utrecht, NetherlandsRegional Academic Cancer Center Utrecht
Sep 22, 2023
Pancreas Adenocarcinoma Trial in Leiden (Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101)
Not yet recruiting
- Pancreas Adenocarcinoma
- Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101
-
Leiden, NetherlandsLeiden University Medical Center
Aug 2, 2023
Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Enfortumab vedotin
-
Kansas City, KansasUniversity of Kansas Cancer Center
Jun 23, 2023
Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Pancreas Adenocarcinoma
- +2 more
- Nab paclitaxel
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023
Breast Cancer, Colorectal Cancer, Oesophageal Cancer Trial in Rozzano, Milano, Pisa ([68Ga]Ga-OncoFAP administration)
Not yet recruiting
- Breast Cancer
- +3 more
- [68Ga]Ga-OncoFAP administration
-
Rozzano, Milano, Italy
- +2 more
Mar 13, 2023
Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma Trial in Saint Louis (device, drug, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- MR-guided stereotactic body radiation therapy
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )
Survival, Quality of Life and Resectability in Locally Advanced
Recruiting
- Pancreas Cancer
- +8 more
-
Umeå, SwedenSurgical Clinic at Umeå University Hospital
Nov 23, 2022
Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500
Recruiting
- Pancreas Adenocarcinoma
- CPI-613® (Dose level -1.0 250 mg/m^2)
- +6 more
-
Detroit, Michigan
- +1 more
Nov 9, 2022
Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts
Recruiting
- Pancreas Adenocarcinoma
- Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
-
Suwon, Gyeong Gi Do, Korea, Republic ofAjou University Hospital
Oct 7, 2022
Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
Active, not recruiting
- Pancreas Adenocarcinoma
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Sep 27, 2022
Pancreas Adenocarcinoma Trial in Worldwide (NovoTTF-100L(P), Gemcitabine, nab paclitaxel)
Recruiting
- Pancreas Adenocarcinoma
- NovoTTF-100L(P)
- +2 more
-
Birmingham, Alabama
- +145 more
Aug 10, 2022
Epithelial Ovarian Carcinoma, Pancreas Adenocarcinoma Trial in Boston, Danvers (Electronic Decision Aid, Pre-Test Genetic
Not yet recruiting
- Epithelial Ovarian Carcinoma
- Pancreas Adenocarcinoma
- Electronic Decision Aid
- Pre-Test Genetic Counseling
-
Boston, Massachusetts
- +1 more
Jul 20, 2022
Cancer Cachexia in Subjects With Panc Adenocarcinoma
Recruiting
- Pancreas Adenocarcinoma
- Cachexia
-
Charlotte, North CarolinaLevine Cancer Institute
Jun 17, 2022
Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic
Recruiting
- Pancreas Adenocarcinoma
- Resectable Pancreatic Cancer
- Gemcitabine 1000 mg
- +2 more
-
Loma Linda, CaliforniaLoma Linda University Health
Jun 14, 2022
Pancreas Cancer, Pancreas Tumor, Pancreas Adenocarcinoma Trial (Laparoscopic surgical biopsy and organoid generation)
Not yet recruiting
- Pancreas Cancer
- +5 more
- Laparoscopic surgical biopsy and organoid generation
- (no location specified)
Apr 22, 2022
Pancreas Cancer, Duct Cell Adenocarcinoma, Pancreas Adenocarcinoma, Peritoneal Metastases Trial in Quebec City (Whole-body
Recruiting
- Pancreas Cancer, Duct Cell Adenocarcinoma
- +3 more
- Whole-body diffusion-weighted magnetic resonance imaging
-
Quebec City, Quebec, CanadaCHU de Québec
Apr 20, 2022
Pancreas Adenocarcinoma Trial (Treatment prediction PDT platform)
Withdrawn
- Pancreas Adenocarcinoma
- Treatment prediction PDT platform
- (no location specified)
Feb 7, 2022
Pancreatic Cancer Dietary Assessment Study
Completed
- Pancreatic Neoplasm
- +3 more
- Pancreo-KIT breath test
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Feb 1, 2022
Pancreas Adenocarcinoma, Dysplasia Trial in Sarasota (LINFU™)
Recruiting
- Pancreas Adenocarcinoma
- Dysplasia
- LINFU™
-
Sarasota, FloridaGastroenterology Associates of Sarasota
Dec 21, 2021